NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/14/2023
Back to search
Official data from USPTO
ONCOPIG CANCER MODEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ONCOPIG CANCER MODEL
ST13
US500000090881858Class
42
Filing
90881858
Registration
7002259
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
03/14/2023
Trademark type
Word
Nice classes
42
Filing date
08/13/2021
Registration date
03/14/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/14/2023
Last transaction
03/14/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
07/17/2020
First use in commerce
07/17/2020
Drawing code
4
Owner type
03
Owner location
Cincinnati, OH, US
Examiner
BELL, MARLENE D
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Sus Clinicals, Inc.
Representatives
Zach Gordon TAFT STETTINIUS & HOLLISTER
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical laboratory services for inducing cancer via inducible translational porcine testing specimens for use in the research and testing of cancer treatmentsdiagnosticsdevicesdrugs
Publications
History of USPTO decisions and trademark events.
18 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
03/14/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/08/2023
ALIE
ASSIGNED TO LIE
02/06/2023
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
01/14/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
01/13/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/13/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
01/13/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/22/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/22/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/22/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/23/2022
GNRT
NON-FINAL ACTION E-MAILED
05/23/2022
CNRT
NON-FINAL ACTION WRITTEN
05/23/2022
DOCK
ASSIGNED TO EXAMINER
05/15/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/04/2021
NWAP
NEW APPLICATION ENTERED
08/17/2021
Continuous trademark protection
Get notified about every new filing that threatens ONCOPIG CANCER MODEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.